Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C17H17NO3S |
| Molecular Weight | 315.387 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC2=C(C=C1)N(C)C3=C(S2)C=CC(=C3)C(C)C(O)=O
InChI
InChIKey=VSQMKHNDXWGCDB-UHFFFAOYSA-N
InChI=1S/C17H17NO3S/c1-10(17(19)20)11-4-7-15-14(8-11)18(2)13-6-5-12(21-3)9-16(13)22-15/h4-10H,1-3H3,(H,19,20)
DescriptionSources: I.K. Morton, Judith M. Hall Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp.342. P.238Curator's Comment: Information on Protizinic acid is too limited. Description was created based on several sources, including http://www.ncbi.nlm.nih.gov/pubmed/7215998
Sources: I.K. Morton, Judith M. Hall Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp.342. P.238
Curator's Comment: Information on Protizinic acid is too limited. Description was created based on several sources, including http://www.ncbi.nlm.nih.gov/pubmed/7215998
Protizinic acid is an elaborated member of propionic acid series, and is a cyclooxygenase inhibitor with antiinflammatory and antipyretic activity
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C257
Created by
admin on Fri Dec 15 16:01:54 GMT 2023 , Edited by admin on Fri Dec 15 16:01:54 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C005911
Created by
admin on Fri Dec 15 16:01:54 GMT 2023 , Edited by admin on Fri Dec 15 16:01:54 GMT 2023
|
PRIMARY | |||
|
237-453-0
Created by
admin on Fri Dec 15 16:01:54 GMT 2023 , Edited by admin on Fri Dec 15 16:01:54 GMT 2023
|
PRIMARY | |||
|
CHEMBL2105285
Created by
admin on Fri Dec 15 16:01:54 GMT 2023 , Edited by admin on Fri Dec 15 16:01:54 GMT 2023
|
PRIMARY | |||
|
DTXSID20864444
Created by
admin on Fri Dec 15 16:01:54 GMT 2023 , Edited by admin on Fri Dec 15 16:01:54 GMT 2023
|
PRIMARY | |||
|
13799-03-6
Created by
admin on Fri Dec 15 16:01:54 GMT 2023 , Edited by admin on Fri Dec 15 16:01:54 GMT 2023
|
PRIMARY | |||
|
N40195UTPI
Created by
admin on Fri Dec 15 16:01:54 GMT 2023 , Edited by admin on Fri Dec 15 16:01:54 GMT 2023
|
PRIMARY | |||
|
C72086
Created by
admin on Fri Dec 15 16:01:54 GMT 2023 , Edited by admin on Fri Dec 15 16:01:54 GMT 2023
|
PRIMARY | |||
|
71862
Created by
admin on Fri Dec 15 16:01:54 GMT 2023 , Edited by admin on Fri Dec 15 16:01:54 GMT 2023
|
PRIMARY | |||
|
100000080856
Created by
admin on Fri Dec 15 16:01:54 GMT 2023 , Edited by admin on Fri Dec 15 16:01:54 GMT 2023
|
PRIMARY | |||
|
m908
Created by
admin on Fri Dec 15 16:01:54 GMT 2023 , Edited by admin on Fri Dec 15 16:01:54 GMT 2023
|
PRIMARY | Merck Index | ||
|
SUB10143MIG
Created by
admin on Fri Dec 15 16:01:54 GMT 2023 , Edited by admin on Fri Dec 15 16:01:54 GMT 2023
|
PRIMARY | |||
|
54323-85-2
Created by
admin on Fri Dec 15 16:01:54 GMT 2023 , Edited by admin on Fri Dec 15 16:01:54 GMT 2023
|
SUPERSEDED | |||
|
2317
Created by
admin on Fri Dec 15 16:01:54 GMT 2023 , Edited by admin on Fri Dec 15 16:01:54 GMT 2023
|
PRIMARY | |||
|
3200
Created by
admin on Fri Dec 15 16:01:54 GMT 2023 , Edited by admin on Fri Dec 15 16:01:54 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
